Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Blot

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Cancer|April 17, 2003
Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressivenessE Blot, W Chen, M Vasse, et al.
Human Gene Therapy|September 30, 2006
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancerJ-Y Pillé, H Li, E Blot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trialM Gross-Goupil, A Fourcade, E Blot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2016
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group studyO Trédan, P Follana, I Moullet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL studyH Bourgeois, F Grudé, P Solal-Céligny, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Cancer|April 17, 2003
Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressivenessE Blot, W Chen, M Vasse, et al.
Human Gene Therapy|September 30, 2006
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancerJ-Y Pillé, H Li, E Blot, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trialM Gross-Goupil, A Fourcade, E Blot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 27, 2016
A phase III trial of exemestane plus bevacizumab maintenance therapy in patients with metastatic breast cancer after first-line taxane and bevacizumab: a GINECO group studyO Trédan, P Follana, I Moullet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL studyH Bourgeois, F Grudé, P Solal-Céligny, et al.
Pageof 2